Haleon profits rise but margins squeezed by cost inflation.
Profits at consumer health company Haleon on Wednesday came in below expectations as higher costs hit earnings margins.
Haleon
03 May 2023 07:35:47
Source: Sharecast
The maker of Advil and Sensodyne generated adjusted earnings per share of 4.2p on revenue of nearly £3bn, compared with analyst expectations for quarterly profit of 5.24p on revenue of about £2.9bn. re-tacx profit rose to £542m from £465m.
Haleon, which spun out as an independent company in July and made up of consumer health assets once owned by GSK and Pfizer, said adjusted profit margin due to "cost inflation and incremental standalone costs".
Last month it said it expected to be closer to the upper range of its predicted 2023 growth of 4-6%.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.